XML 163 R27.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Organization and Description of Business (Details) $ / shares in Units, $ in Thousands |  |  |  |  |  |  | 1 Months Ended | 12 Months Ended |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Apr. 12, 2024 | Oct. 30, 2023 USD ($) | Oct. 26, 2023 $ / shares shares | Jul. 28, 2023 USD ($) | Mar. 15, 2023 shares | Mar. 03, 2023 | Apr. 30, 2024 | Dec. 31, 2023 USD ($) $ / shares | Dec. 31, 2022 USD ($) $ / shares | Sep. 30, 2024 USD ($) $ / shares | Dec. 31, 2021 $ / shares
Reverse stock split ratio |  |  |  |  | 0.0667 |  |  |  |  |  |
Number of fractional shares issued in connection with the Reverse Stock Split | shares |  |  |  |  | 0 |  |  |  |  |  |
Accumulated deficit | $ |  |  |  |  |  |  |  | $ (380,971) | $ (329,369) | $ (395,771) |
Number of positions eliminated period percent | 81.00% |  |  |  |  |  | 81.00% |  |  |  |
Exercise price of warrant |  |  |  |  |  |  |  | $ 67.16 | $ 1,152.94 | $ 14.39 | $ 6,036.53
Proceeds from issuance of common shares - Registered Direct Offering | $ |  | $ 4,400 |  |  |  |  |  | $ 4,398 | $ 0 |  |
Offering costs for the issuance of common shares - Registered Direct Offering | $ |  | $ 500 |  |  |  |  |  | $ (443) | $ 0 |  |
Common stock par value (in dollars per share) |  |  |  |  |  |  |  | $ 0.0001 | $ 0.0001 | $ 0.0001 |
Amended Asset Purchase Agreement | uBriGene |  |  |  |  |  |  |  |  |  |  |
Asset purchase agreements, base consideration | $ |  |  |  | $ 6,000 |  |  |  |  |  |  |
Asset purchase agreement, contingent consideration less severance obligation | $ |  |  |  | $ 5,000 |  |  |  |  |  |  |
Number of years after the closing date |  |  |  | 2 years |  |  |  |  |  |  |
Securities Purchase Agreement |  |  |  |  |  |  |  |  |  |  |
Issuance of common shares (in shares) | shares |  |  | 18,400 |  |  |  |  |  |  |  |
Shares issued, price per share |  |  | $ 85 |  |  |  |  |  |  |  |
Common stock par value (in dollars per share) |  |  | $ 0.0001 |  |  |  |  |  |  |  |
Securities Purchase Agreement | Warrants |  |  |  |  |  |  |  |  |  |  |
Warrants issued | shares |  |  | 33,364 |  |  |  |  |  |  |  |
Exercise price of warrant |  |  | $ 84.95 |  |  |  |  |  |  |  |
Discount on price per share in warrant exercise |  |  | $ 0.05 |  |  |  |  |  |  |  |
Private Placement | Warrants |  |  |  |  |  |  |  |  |  |  |
Warrants issued | shares |  |  | 3,104 |  |  |  |  |  |  |  |
Exercise price of warrant |  |  | $ 79 |  |  |  |  |  |  |  |
Warrants expiration term |  |  | 5 years 6 months |  |  |  |  |  |  |  |
Offering price per share |  |  | $ 0.125 |  |  |  |  |  |  |  |
Maximum |  |  |  |  |  |  |  |  |  |  |
Reverse stock split ratio |  |  |  |  |  | 0.05 |  |  |  |  |
Minimum |  |  |  |  |  |  |  |  |  |  |
Reverse stock split ratio |  |  |  |  |  | 0.2 |  |  |  |  |
Minimum | Amended Asset Purchase Agreement | uBriGene |  |  |  |  |  |  |  |  |  |  |
Issuance of equity securities | $ |  |  |  | $ 10,000 |  |  |  |  |  |  |

X
- Definition The amount of base consideration for sale of all of the Company's assets primarily relating to the Company's operations primarily relating to the manufacturing and production of cell and gene therapies to uBriGene. + References No definition available. + Details
Name: | mbio_AssetPurchaseAgreementBaseConsideration
Namespace Prefix: | mbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount contingent amount of $5.0 million less certain severance obligations and payments payable in connection with the transfer of certain contracts related to the transferred assets + References No definition available. + Details
Name: | mbio_AssetPurchaseAgreementContingentConsiderationLessSeveranceObligations
Namespace Prefix: | mbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of equity securities issued in pursuant to the Asset Purchase Agreement. + References No definition available. + Details
Name: | mbio_IssuanceOfEquitySecuritiesInPursuantToAssetPurchaseAgreement.
Namespace Prefix: | mbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The proceeds from issuance of common shares in a registered direct offering. + References No definition available. + Details
Name: | mbio_ProceedsFromIssuanceOfCommonSharesInRegisteredDirectOffering
Namespace Prefix: | mbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Cash proceeds from (payments) for offering costs on the issuance of common shares for a registered direct offering. + References No definition available. + Details
Name: | mbio_ProceedsFromPaymentsForOfferingCostsOnIssuanceOfCommonSharesForRegisteredDirectOffering
Namespace Prefix: | mbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The period of time after the closing date of Asset Purchase Agreement. + References No definition available. + Details
Name: | mbio_StockPurchaseAgreementPeriodAfterClosingDate
Namespace Prefix: | mbio_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Ratio applied to the conversion of reverse stock split, for example but not limited to, one share converted to two or two shares converted to one. + References No definition available. + Details
Name: | mbio_StockholdersEquityNoteReverseStockSplitConversionRatio
Namespace Prefix: | mbio_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | duration

X
- Definition Offering price per share of warrants. + References No definition available. + Details
Name: | mbio_WarrantOfferingPricePerShare
Namespace Prefix: | mbio_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Represents the discount off of share price for redemption of warrants. + References No definition available. + Details
Name: | mbio_WarrantsDiscountOnPricePerShareIssued
Namespace Prefix: | mbio_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s). + References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of accumulated undistributed earnings (deficit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)(a)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(23)(a)(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(17)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_RetainedEarningsAccumulatedDeficit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Reduction in the number of shares during the period as a result of a reverse stock split. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=mbio_AmendedAssetPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=mbio_UbrigeneBiosciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=mbio_SecuritiesPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |